• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤进展会抑制过继转移的肿瘤特异性CD8 + T细胞多功能性的诱导。

Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells.

作者信息

Imai Naoko, Ikeda Hiroaki, Tawara Isao, Shiku Hiroshi

机构信息

Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Japan.

出版信息

Eur J Immunol. 2009 Jan;39(1):241-53. doi: 10.1002/eji.200838824.

DOI:10.1002/eji.200838824
PMID:19089817
Abstract

It is becoming increasingly evident that the multifunctionality of effector cells at the single-cell level is an important factor to predict the quality of T-cell response in immunological protection. The significance of the multifunctionality of T cells in anti-tumor immunity, however, remains unclear. Here, we assessed the IFN-gamma and TNF-alpha production and CD107a mobilization in adoptively transferred tumor-antigen-specific CD8(+) T cells at the single-cell level. Tumor growth of the murine fibrosarcoma CMS5 was found to limit the induction of multifunctionality in the transferred cells. These cells exhibited insufficient acquisition of the CD25(high)GITR(high)CD62L(low) phenotype and reduced infiltration in tumor. Depletion of Treg facilitated the induction of high multifunctionality of the transferred cells even in the hosts with progressing tumor, leading to enhanced tumor regression. The multifunctionality of the transferred cells correlated with in vivo CTL activity, and T cells with high multifunctionality harvested from hosts with successful therapy induced tumor regression when re-transferred into the tumor-bearing hosts. These data suggest that the appearance of multifunctional CD8(+) effector T cells in vivo is a critical determinant of the success of anti-tumor immunotherapy and Treg play an important role in the mechanism inhibiting the induction of multifunctionality in effector cells.

摘要

越来越明显的是,效应细胞在单细胞水平上的多功能性是预测免疫保护中T细胞反应质量的一个重要因素。然而,T细胞多功能性在抗肿瘤免疫中的意义仍不清楚。在这里,我们在单细胞水平上评估了过继转移的肿瘤抗原特异性CD8(+) T细胞中IFN-γ和TNF-α的产生以及CD107a的动员。发现小鼠纤维肉瘤CMS5的肿瘤生长限制了转移细胞中多功能性的诱导。这些细胞表现出CD25(高)GITR(高)CD62L(低)表型的获得不足以及肿瘤浸润减少。Treg的耗竭促进了即使在肿瘤进展的宿主中转移细胞的高多功能性诱导,导致肿瘤消退增强。转移细胞的多功能性与体内CTL活性相关,并且从成功治疗的宿主中收获的具有高多功能性的T细胞在重新转移到荷瘤宿主中时诱导肿瘤消退。这些数据表明,体内多功能CD8(+)效应T细胞的出现是抗肿瘤免疫治疗成功的关键决定因素,并且Treg在抑制效应细胞中多功能性诱导的机制中起重要作用。

相似文献

1
Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells.肿瘤进展会抑制过继转移的肿瘤特异性CD8 + T细胞多功能性的诱导。
Eur J Immunol. 2009 Jan;39(1):241-53. doi: 10.1002/eji.200838824.
2
Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression.糖皮质激素诱导的肿瘤坏死因子受体刺激增强了过继转移的肿瘤抗原特异性CD8 + T细胞的多功能性并导致肿瘤消退。
Cancer Sci. 2009 Jul;100(7):1317-25. doi: 10.1111/j.1349-7006.2009.01179.x. Epub 2009 Apr 29.
3
Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.体外激活的效应性CD8 + T细胞在体内可提供即时和长期的肿瘤保护。
Eur J Immunol. 2008 Oct;38(10):2886-95. doi: 10.1002/eji.200838483.
4
Stimulation through very late antigen-4 and -5 improves the multifunctionality and memory formation of CD8⁺ T cells.通过晚期抗原-4 和 -5 的刺激可改善 CD8⁺ T 细胞的多功能性和记忆形成。
Eur J Immunol. 2014 Jun;44(6):1747-58. doi: 10.1002/eji.201343969. Epub 2014 May 11.
5
A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.转录因子NFATc2通过CD8 + T淋巴细胞在支气管腺癌中发挥关键调节作用。
Cancer Res. 2009 Apr 1;69(7):3069-76. doi: 10.1158/0008-5472.CAN-08-1678. Epub 2009 Mar 24.
6
Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.肿瘤特异性CD8 +细胞毒性T淋巴细胞(CTL)与抗CD25单克隆抗体的联合应用可提供更好的免疫治疗效果。
Oncol Rep. 2008 May;19(5):1265-70.
7
Redox modulation inhibits CD8 T cell effector function.氧化还原调节抑制CD8 T细胞效应功能。
Free Radic Biol Med. 2008 Nov 15;45(10):1477-86. doi: 10.1016/j.freeradbiomed.2008.08.023. Epub 2008 Sep 9.
8
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.
9
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.糖皮质激素诱导的肿瘤坏死因子受体信号传导诱导的调节性T细胞抗性CD8 + T细胞。
Cancer Res. 2008 Jul 15;68(14):5948-54. doi: 10.1158/0008-5472.CAN-07-5839.
10
The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.治疗剂量阿司匹林处理的小鼠中功能性CD4+CD25+Foxp3+调节性T细胞的频率显著增加。
Transpl Immunol. 2009 Mar;20(4):253-60. doi: 10.1016/j.trim.2008.12.001. Epub 2009 Jan 13.

引用本文的文献

1
The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).术前免疫营养对膀胱切除术后发病率和免疫反应的作用:一项多中心随机对照试验(INCyst 试验)方案。
Trials. 2024 Oct 17;25(1):687. doi: 10.1186/s13063-024-08536-5.
2
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.针对异基因移植后复发白血病的错配 HLA-DPB1 靶向 TCR-T 细胞治疗的开发。
Int J Hematol. 2023 Aug;118(2):252-266. doi: 10.1007/s12185-023-03621-y. Epub 2023 Jun 13.
3
Activated T cell therapy targeting glioblastoma cancer stem cells.
针对胶质母细胞瘤肿瘤干细胞的活化 T 细胞治疗。
Sci Rep. 2023 Jan 5;13(1):196. doi: 10.1038/s41598-022-27184-w.
4
Tumor-Specific CD4 T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4 T Cells.肿瘤特异性 CD4 T 细胞通过分化为细胞毒性 CD4 T 细胞来抑制已建立的转移性黑色素瘤。
Front Immunol. 2022 Jun 16;13:875718. doi: 10.3389/fimmu.2022.875718. eCollection 2022.
5
Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement.可植入光纤用于免疫治疗药物输送和肿瘤阻抗测量。
Nat Commun. 2021 Aug 26;12(1):5138. doi: 10.1038/s41467-021-25391-z.
6
Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis.胃癌中的浸润性免疫细胞:一种新的预后预测模型
J Cancer. 2021 Jan 1;12(4):965-975. doi: 10.7150/jca.51079. eCollection 2021.
7
Edible -Derived Protein as a Potential Nutraceutical for Anticancer Immunity Improvement.食用蛋白作为一种潜在的抗癌免疫改善营养保健品。
Nutrients. 2020 Oct 22;12(11):3236. doi: 10.3390/nu12113236.
8
CD4 T cells support polyfunctionality of cytotoxic CD8 T cells with memory potential in immunological control of tumor.CD4 T 细胞支持具有记忆潜能的细胞毒性 CD8 T 细胞的多功能性,从而在肿瘤的免疫控制中发挥作用。
Cancer Sci. 2020 Jun;111(6):1958-1968. doi: 10.1111/cas.14420. Epub 2020 May 12.
9
DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy.二酰甘油激酶α:癌症介导的免疫抑制中的一个检查点及免疫治疗靶点。
Front Cell Dev Biol. 2017 Mar 3;5:16. doi: 10.3389/fcell.2017.00016. eCollection 2017.
10
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.白细胞介素-10的表达定义了由抗肿瘤治疗性疫苗接种诱导产生的免疫抑制性树突状细胞群体。
Oncotarget. 2017 Jan 10;8(2):2659-2671. doi: 10.18632/oncotarget.13736.